- Home
- RVMD vs RVTY Comparison
RVMD vs RVTY Comparison
Compare RVMD & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVMD | RVTY |
|---|---|---|
| Founded | 2014 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2B | 13.2B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | RVMD | RVTY |
|---|---|---|
| Price | $96.84 | $103.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 15 |
| Target Price | $102.63 | ★ $113.00 |
| AVG Volume (30 Days) | ★ 5.7M | 1.6M |
| Earning Date | 02-25-2026 | 02-02-2026 |
| Dividend Yield | N/A | ★ 0.28% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.07 |
| Revenue | N/A | ★ $2,856,051,000.00 |
| Revenue This Year | N/A | $4.69 |
| Revenue Next Year | $740.40 | $5.72 |
| P/E Ratio | ★ N/A | $48.89 |
| Revenue Growth | N/A | ★ 3.67 |
| 52 Week Low | $29.17 | $81.36 |
| 52 Week High | $124.49 | $126.57 |
Technical Indicators
Market Signals| Indicator | RVMD | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 45.96 | 44.01 |
| Support Level | $96.72 | $100.62 |
| Resistance Level | $98.64 | $109.29 |
| Average True Range (ATR) | 3.97 | 4.12 |
| MACD | -3.23 | -1.63 |
| Stochastic Oscillator | 12.07 | 17.28 |
Price Performance
Historical ComparisonAbout RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
About RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.